Share 35 政策实施后肝移植术后死亡率改善
该研究基于器官获取与移植网络/器官共享联合网络数据库,纳入2010年1月1日至2016年3月31日全部成人 deceased donor 肝移植,评估 Share 35 实施前后1年患者生存。结果显示 MELD≥35 患者1年生存从83.9%提高至88.4%(P<0.01),MELD<35 患者无显著影响(P=0.69);多变量 Cox 分析中 Share 35 与 MELD≥35 受者1年生存改善相关(HR 0.69,95%CI 0.60-0.80)。
要点
- Share 35 实施后 MELD≥35 肝移植受者1年生存从83.9%提高至88.4%(P<0.01)。
- MELD<35 患者1年生存未受显著影响(P=0.69)。
- MELD≥35 受者中 Share 35 与1年生存改善相关(HR 0.69,95%CI 0.60-0.80)。
核心结论
- Share 35 对 MELD≥35 患者移植后生存有积极影响,且未对病情较轻患者造成相应损害,部分归因于更有利的供受者匹配。
研究设计与样本
- 回顾性队列分析,数据来自器官获取与移植网络/器官共享联合网络数据库,纳入2010年1月1日至2016年3月31日全部成人 deceased donor 肝移植,共34,975例受者。
主要发现
- 34,975例成人肝移植受者中,16,472例(47.1%)在 Share 35 实施后接受移植,其中4,599例(27.9%)MELD评分≥35。
- MELD≥35 患者1年生存率在 Share 35 实施后从83.9%提高至88.4%(P<0.01)。
- MELD<35 患者1年生存率无显著影响(P=0.69)。
- 以不含区域共享成分的供者风险指数衡量,MELD≥35 患者的供者器官质量改善(P<0.01),而 MELD 较低患者的供者器官质量变差(P<0.01)。
- 多变量 Cox 回归分析中,MELD≥35 受者接受 Share 35 与1年患者生存改善相关(HR 0.69,95%CI 0.60-0.80)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: The Share 35 policy was implemented in June 2013 to improve equity in access to liver transplantation (LT) between patients with fulminant liver failure and those with cirrhosis and severe hepatic decompensation. The aim of this study was to assess post-LT outcomes after Share 35. Relevant donor, procurement, and recipient data were extracted from the Organ Procurement and Transplantation Network/United Network for Organ Sharing database. All adult deceased donor LTs from January 1, 2010, to March 31, 2016, were included in the analysis. One-year patient survival before and after Share 35 was assessed by multivariable Cox proportional hazards analysis, with adjustment for variables known to affect graft survival. Of 34,975 adult LT recipients, 16,472 (47.1%) were transplanted after the implementation of Share 35, of whom 4,599 (27.9%) had a Model for End-Stage Liver Disease (MELD) score ≥35. One-year patient survival improved from 83.9% to 88.4% after Share 35 (P < 0.01) for patients with MELD ≥35. There was no significant impact on survival of patients with MELD <35 (P = 0.69). Quality of donor organs, as measured by a donor risk index without the regional share component, improved for patients with MELD ≥35 (P < 0.01) and worsened for patients with lower MELD (P < 0.01). In multivariable Cox regression analysis, Share 35 was associated with improved 1-year patient survival (hazard ratio, 0.69; 95% confidence interval, 0.60-0.80) in recipients with MELD ≥35. CONCLUSION: Share 35 has had a positive impact on survival after transplantation in patients with MELD ≥35, without a reciprocal detriment in patients with lower acuity; this was in part a result of more favorable donor-recipient matching. (Hepatology 2018;67:273-281).
引用
- Kwong AJ, Goel A, Mannalithara A, et al. Improved posttransplant mortality after share 35 for liver transplantation. Hepatology. 2017. PMID: 28586179. doi:10.1002/hep.29301
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。